{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:04:02Z","timestamp":1790798642706,"version":"4.1.0"},"reference-count":13,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jtha.2026.06.040","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:43:11Z","timestamp":1790797391000},"page":"3446-3449","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Vascular endothelial growth factor inhibition and anticoagulation: focus on mucosal bleeding and platelet count"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2539-8038","authenticated-orcid":false,"given":"Aaron Leonid","family":"Sverdlov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Reardon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doan Minh Thi","family":"Ngo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2026.06.040_bib1","first-page":"3553","article-title":"Bleeding in patients with lung adenocarcinoma receiving concurrent administration of anticoagulation and vascular endothelial growth factor or epidermal growth factor receptor inhibitors","volume":"24","author":"Fusillo","year":"2026","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.040_bib2","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1111\/jth.13140","article-title":"Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH","volume":"13","author":"Kaatz","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.040_bib3","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","volume":"3","author":"Schulman","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.040_bib4","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1038\/sj.bjc.6603813","article-title":"Mechanisms of adverse effects of anti-VEGF therapy for cancer","volume":"96","author":"Kamba","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jtha.2026.06.040_bib5","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1161\/ATVBAHA.119.313021","article-title":"Weibel-Palade bodies orchestrate pericytes during angiogenesis","volume":"39","author":"Cossutta","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2026.06.040_bib6","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/jth.14322","article-title":"Exocytosis of Weibel-Palade bodies: how to unpack a vascular emergency kit","volume":"17","author":"Schillemans","year":"2019","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.040_bib7","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s11239-025-03151-w","article-title":"Tyrosine kinase inhibitors - balancing the haemostatic scales: a review of associated thrombosis and bleeding","volume":"59","author":"Butel-Simoes","year":"2026","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.jtha.2026.06.040_bib8","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/cncr.33337","article-title":"Increased bleeding risk associated with concurrent vascular endothelial growth factor receptor tyrosine kinase inhibitors and low-molecular-weight heparin","volume":"127","author":"Patel","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.jtha.2026.06.040_bib9","doi-asserted-by":"crossref","first-page":"e2061","DOI":"10.1002\/onco.13897","article-title":"Retrospective study of bleeding risk with concomitant vascular endothelial growth factor receptor tyrosine kinase inhibitor and anticoagulation","volume":"26","author":"Sivakumar","year":"2021","journal-title":"Oncologist"},{"key":"10.1016\/j.jtha.2026.06.040_bib10","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1053\/j.seminoncol.2023.05.002","article-title":"Bleeding risk with concomitant administration of VEGF-TKIs and anticoagulant agents","volume":"50","author":"Verso","year":"2023","journal-title":"Semin Oncol"},{"key":"10.1016\/j.jtha.2026.06.040_bib11","first-page":"41","article-title":"Safety of direct oral anticoagulants in patients with advanced solid tumors receiving anti-VEGF agents: a retrospective study","volume":"31","author":"Boileve","year":"2022","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jtha.2026.06.040_bib12","article-title":"Tranexamic acid in bleeding management of advanced cancer in palliative care: a systematic review","volume":"37","author":"Huang","year":"2026","journal-title":"Clin Epidemiol Glob Health"},{"key":"10.1016\/j.jtha.2026.06.040_bib13","doi-asserted-by":"crossref","first-page":"e09","DOI":"10.15420\/cfr.2025.44","article-title":"Integrated cardio-oncology service","volume":"12","author":"Butel-Simoes","year":"2026","journal-title":"Card Fail Rev"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626004265?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626004265?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:43:59Z","timestamp":1790797439000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783626004265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":13,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1538783626004265"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2026.06.040","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vascular endothelial growth factor inhibition and anticoagulation: focus on mucosal bleeding and platelet count","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2026.06.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2026.05.028","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}